Study on the antioxidant status of vitiligo patients of different age groups in Baroda

Pigment Cell Research

Volumn 17, Issue 3, 2004, Pages 289-294

  Agrawal, Deepali ^a   Shajil, E M ^a   Marfatia, Y S ^b   Begum, Rasheedunnisa ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b Baroda Medical College   (India)

Author keywords

Age dependent; Catalase; Glutathione peroxidase; Superoxide dismutase; Systemic oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DEPIGMENTATION; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; SKIN DISEASE; VITILIGO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIOXIDANTS; CATALASE; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; INDIA; LIPID PEROXIDATION; MIDDLE AGED; SUPEROXIDE DISMUTASE; VITAMIN E; VITILIGO;

EID: 2642546390     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2004.00149.x     Document Type: Article

References (45)

1. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y, Hypomelnosis and hypermelanosis. In: Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Kats SI, Fitzpatrick TB, eds. Dermatology in General Medicine. New York: Mc Graw Hill; 1999. pp. 945-1017
2. Nordlund JJ, Ortonne JP. Vitiligo vulgaris. In: Nordlund JJ, Boissey RE, Hearing VJ, King RA, Ortonne JP, eds. The Pigmentary System. Physiology and Pathophysiology. New York: Oxford University Press; 1998. pp. 513-551
3. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999;10:653-657
4. Das SK, Majumder PP, Chakraborty R, Majumdar TK, Haldar B. Studies on vitiligo. 1. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985;1:71-78
5. Valia AK, Dutta PK. IADVL Text book and Atlas of Dermatology. Bombay: Bhalani Publishing House; 1996. pp. 500-586
6. Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 2000;8:41-47
7. Dell'Anna ML, Maresca V, Brigandi S, Camrea E, Falchi M, Picardo M. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 2001;4:908-913
8. Le Poole IC, Das PK, Van Den Wijngaard RM, Bose JD, Westerhof W. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993;2:146-153
9. Ortonne JP, Bose SK. Vitiligo: Where do we stand? Pigment Cell Res 1993;8:61-72
10. Agrawal D, Sahani MH, Gupta S, Begum R. Vitiligo etiopathogenesis and therapy - a review. Journal of the Maharaja Sayajirao University of Baroda 2001;48:97-106
11. Cucchi ML, Frattini P, Santagostino G, Preda S, Orecchia G. Catecholamines increase in the urine of non segmental vitiligo especially during its active phase. Pigment Cell Res 2003;2:111-116
12. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003;2:90-100
13. Boisseau-Garsaud P, Lejoly-Boissaeu H, Robert M, Quist D, Arveiler B. Increase in the total antioxidant status and selenium levels in the black patients with active vitiligo. Int J Dermatol 2002;10:640-642
14. Picardo M, Passi S, Morrone A, Grandinetti M. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994;2:110-115
15. Yildirim M, Baysal V, Inaloz HS, Kesici D, Delibas N. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 2003;2:104-108
16. Nishikimi M, Appaji N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Comm 1972;46:849-854
17. Aebi H. Catalase in vitro. Meth Enzymol 1984;105:121-123
18. Beutler E. Nutritional and metabolic aspect of glutathione. Annu Rev Nutr 1989;9:287-302
19. Beutler E, Duron O, Kelly BM. Improved method for the reduced glutathione. J Lab Clin Med 1969;61:882-888
20. Hansen LG, Warwick WJ. A fluorometric micromethod for serum vitamins A and E. Am J Clin Pathol 1969;51:538-541
21. Kornberg A, Horecker BL. Spectrophotometric method for the estimation of Glucose 6 phosphate dehydrogenase in erythrocytes. Meth Enzymol 1955;1:123-126
22. Beuge JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978;52:302-310
23. Passi S, Grandinetti M, Maggio F, Stancato A, De Luca C. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998;2:81-85
24. Hann SK, Chun WH. Autocytotoxic hypothesis for the destruction of melanocytes as the cause of vitiligo. In: Nordlund JJ, Hann SK, eds. Vitiligo a monograph on the basic and clinical science. Oxford: Blackwell Science; 2001. pp. 137-141
25. Schallreuter KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996;1:11-13
26. Schallreuter KU, Pittelkow MP. Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch Dermatol Res 1988;3:137-139
27. Schallreuter KU, Wood JM, Ziegler I, Lemke KR, Pittelkow MR, Lindsey NJ, Gutlich M. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta 1994;2:181-192
28. 2 accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol 2001;1:167-174
29. Schallreuter KU, Wood JM, Pittelkow MR, Buttner G, Swanson N, Korner C, Ehrke C. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res 1996;1:14-18
30. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;6:1081-1085
31. Morrone A, Picardo M, Deluca C, Teminali O. Catecholamines and vitiligo. Pigment Cell Res 1992;5:58-62
32. Thody AJ, Higgins EM, Wakamstu K, Ito S. Pheomelanin as well as eumelanin is present in human epidermis. J Invest Dermatol 1991;97:340-344
33. Riley PA. Radicals in melanin biochemistry. Ann N Y Acad Sci 1988;55:111-120
34. McCord JM, Fridovich I. Superoxide dismutase: an enzyme function of eythrocuprein (hemocuprin). J Biol Chem 1969;244:6049-6055
35. Chakraborty DP, Roy S, Chakraborty AK. Vitiligo, psoralen, and melanogenesis: some observations and understanding. Pigment Cell Res 1996;9:107-116
36. Beazley WD, Gaze D, Panske A, Panzig B. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999;141:301-303
37. Maresca V, Roccella M, Roccella F, Camera E. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997;109:945-977
38. Schallreuter KU, Wood J, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;97:1081-1085
39. Little C, O'Brien PJ. An intracellular GSH-peroxidase with a lipid peroxide substrate. Biochem Biophys Res Commun 1968;31:145-147
40. Christopherson BO. Formation of monohydroxy-polyenic-fatty acids from lipid peroxides by glutathione peroxidase. Biochim Biophys Acta 1968;164:35
41. Saha N, Ahmed MA, Wasfi AI, El Munshid HA. Distribution of serum proteins, red cell enzymes and hemoglobin in vitiligo. Hum Hered 1982;32:46-48
42. Mehta AB. Glucose-6-phosphate dehydrogenase deficiency. Post Grad Med J 1991;70:871-877
43. Sodecinde O. Glucose-6-phosphate dehydrogenase deficiency. Baill Clin Hematol 1992;5:367-382
44. Agrawal D, Sahani MH, Gupta S, Begum R. Antioxidant status of vitiligo patients. Poster presentation at the 'Second International Symposium on Molecular Medicine with special reference to the molecular and pharmacological aspects of allergy and related diseases' held at Baroda from 20th to 23rd January 2002.
45. Agrawal D. Antioxidant status of vitiligo patients relative to controls. MPhil Dissertation. Vadodara: Biochemistry Department, M.S. University of Baroda; 2002.